The Heart Failure Congress is renowned worldwide for its comprehensive coverage of everything related to heart failure, from prevention to treatment. Organised by the Heart Failure Association of the ESC, this annual meeting is dedicated to advancing knowledge, improving patient care, and fostering collaboration in the field.

This year's edition, held both in Lisbon and online, promises an exceptional program curated by esteemed experts in the field. From insightful sessions to groundbreaking research presented in the Late-Breaking Science segment, there's something for everyone keen to delve into the latest advancements in heart failure management.

The Richmond team will be joining for an enriching experience filled with discovery, learning, and networking opportunities. 

To find out more, please visit https://www.escardio.org/Congresses-Events/Heart-Failure 

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event